A study to access the complications arising for the mother and the baby after an emergency caesarean sectio
Not Applicable
- Conditions
- Health Condition 1: O759- Complication of labor and delivery, unspecified
- Registration Number
- CTRI/2024/06/069281
- Lead Sponsor
- Dr Angeline Veronica A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Gestational age 28 weeks or more
2. Any pregnant women who deliver by undergoing Primary Caesarean Sections - Primigravida , women with one or more previous vaginal deliveries, previous instrumental deliveries, previous assisted deliveries, previous stillbirth, previous intrauterine death
Exclusion Criteria
1. Patients who had undergone any previous uterine surgeries like previous Caesarean Sections, previous myomectomy
2. Previous abortions
3. Electively planned Caesarean Sections
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways are associated with maternal and neonatal complications following emergency primary caesarean sections?
How do emergency primary caesarean sections compare to planned caesarean and vaginal deliveries in terms of fetomaternal complication rates?
Which biomarkers can predict adverse outcomes in mothers and infants after emergency primary caesarean sections?
What are the most common adverse events observed in emergency primary caesarean sections and their management strategies?
What therapeutic strategies are currently used to mitigate complications from emergency primary caesarean sections in clinical practice?